Adriana Parise

Ms. Adriana Parise

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2023 in Viruses
Verified
Journal Article
Open access
PDF file
LCLia Cunha
Lia Cunha
Adriana LuchsAdriana Luchs
Adriana Luchs
LALais S. Azevedo
Lais S. Azevedo
VSVanessa Cristina Martins Silva
Vanessa Cristina Martins Silva
MLMarcilio F. Lemos
Marcilio F. Lemos
RMRegina Célia Moreira
Regina Célia Moreira
Hepatitis E virus (HEV) is an emerging zoonotic pathogen associated with relevant public health issues. The aim of this study was to investigate HEV presence in free-living capybaras inhabiting urban parks in São Paulo state, Brazil. Molecular characterization of HEV positive samples was undertaken to elucidate the genetic diversity of the virus in these animals. A total of 337 fecal samples were screened for HEV using RT-qPCR and further confirmed by conventional nested RT-PCR. HEV genotype and subtype were determined using Sanger and next-generation sequencing. HEV was detected in one specimen (0.3%) and assigned as HEV-3f. The IAL-HEV_921 HEV-3f strain showed a close relationship to European swine, wild boar and human strains (90.7–93.2% nt), suggesting an interspecies transmission. Molecular epidemiology of HEV is poorly investigated in Brazil; subtype 3f has been reported in swine. This is the first report of HEV detected in capybara stool samples worldwide.

Verified
Journal Article
Open access
PDF file
ACAna Rita Coimbra Coimbra Motta de Castro
Ana Rita Coimbra Coimbra Motta de Castro
LKLIGIA REGINA FRANCO SANSIGOLO KERR
LIGIA REGINA FRANCO SANSIGOLO KERR
CKCarl Kendall
Carl Kendall
RMRosa S. Mota
Rosa S. Mota
MGMark Drew C. Guimarães
Mark Drew C. Guimarães
RMRegina Célia Moreira
Regina Célia Moreira
Hepatitis B virus (HBV) is a global public health problem and requires specific prevention actions, particularly focusing on the key populations, such as men who have sex with men (MSM). We aimed at assessing the prevalence of HBV infection, among MSM, in a multicity study in Brazil. In 2016, we conducted a survey using a respondent-driven sampling methodology in 12 Brazilian cities. Rapid tests (RT) were performed on 3178 samples from those MSM. Positive results were tested for HBV DNA and sequenced. If negative for HBV DNA, samples were tested for serological markers. The prevalence rate of HBV exposure and clearance was 10.1% (95% CI: 8.1–12.6), and 1.1% (95%; CI: 0.6–2.1) were confirmed to be HBsAg-positive. Of those samples tested for anti-HBs (n = 1033), only 74.4% presented a serological profile analogous to that elicited by hepatitis B vaccination. Among HBsAg-positive samples (n = 29), 72.4% were HBV DNA-positive, and from these, 18 were sequenced. HBV genotypes A, F, and G were found in 55.5%, 38.9%, and 5.6%, respectively. This study indicates high prevalence rates of MSM HBV exposure and a low positivity index for the serological marker of HBV vaccine immunity. These findings may contribute to the discussion of strategies to prevent hepatitis B and reinforce the importance of promoting HBV vaccination in this key population.

1 January 2024 in Revista Brasileira de Epidemiologia
Verified
Journal Article
Open access
PDF file
RMRegina Célia Moreira
Regina Célia Moreira
MVMaria Amélia de Sousa Mascena Veras
Maria Amélia de Sousa Mascena Veras
CACarolina Amianti
Carolina Amianti
DMDaniel Jason McCartney
Daniel Jason McCartney
VSVanessa Cristina Martins Silva
Vanessa Cristina Martins Silva
ACAna Rita Coimbra Coimbra Motta de Castro
Ana Rita Coimbra Coimbra Motta de Castro
To estimate the prevalence and factors associated with hepatitis A, B, and C in transgender women and travestis's networks, in 5 regions of Brazil.

29 March 2025 in Viruses
Verified
Journal Article
Open access
PDF file
Adriana LuchsAdriana Luchs
Adriana Luchs
NANatanael Sutikno Adiwardana
Natanael Sutikno Adiwardana
LRLeonardo Cecilio da Rocha
Leonardo Cecilio da Rocha
EVEllen Viana
Ellen Viana
SGSimone Guadagnucci
Simone Guadagnucci
MNMauricio Nogueira
Mauricio Nogueira
Pneumonia and diarrhea are the leading causes of death in children under 5 globally, worsened by viral infections. This study investigates viral agents in children ≤ 3 years with respiratory illness and diarrhea in Metropolitan Region of São Paulo, Brazil, during spring 2021. Twenty paired samples (oropharyngeal swab and feces) were tested using in-house qPCR for HBoV and HAdV, RT-qPCR for RVA, EV, PeV-A, and NoV, and a commercial RT-qPCR kit for SARS-CoV-2, Flu A/B, and RSV. HAstV was detected with conventional nested (RT)-PCR. Positive samples were sequenced for molecular characterization and phylogenetic analysis. Seven viruses were identified: HBoV, NoV, HAdV, PeV-A, EV, RSV, and Flu A. HBoV and NoV were detected in 75% of cases, with co-infection in 65% of patients, indicating their involvement in the gastro-respiratory illness. Genotyping of HBoV (HBoV-1), NoV (GII.4_Sydney[P16], GII.2[P16], and GII.4_Sydney[P31]), EV (Coxsackievirus A6), HAdV (species C, type 6), and PeV-A (genotype 1) showed local virus diversity. Phylogenetic analysis indicated no ongoing community outbreak, with distinct clusters observed. The findings highlight the overlap of respiratory and enteric diseases, revealing local viral diversity and high exposure to enteric viruses. This underscores the challenges in differential diagnosis and the need for syndromic surveillance.

29 April 2024 in BEPA. Boletim Epidemiológico Paulista
Verified
Journal Article
Open access
PDF file
GAGabriela Nardini Allarcon
Gabriela Nardini Allarcon
MLMarcilio Figueiredo Lemos
Marcilio Figueiredo Lemos
VSVanessa Cristina Martins Silva
Vanessa Cristina Martins Silva
CCClovis Roberto Abe Constantino
Clovis Roberto Abe Constantino
APAdriana Parise
Adriana Parise
A hepatite C é uma das principais causas de doença hepática crônica, cirrose e carcinoma hepatocelular. Estima-se que 58 milhões de pessoas tenham infecção crônica com cerca de 1,5 milhão de novas infecções por ano. Em 2016, a OMS estipulou a meta de eliminar as hepatites virais até 2030, reduzindo em 90% as novas infecções e em 65% as mortes. Este relato de experiência se propõe a apresentar os avanços no diagnóstico e tratamento da hepatite C no período de 2000 a 2023 e discutir os desafios ainda presentes para atingir a meta da OMS. O diagnóstico da Hepatite C envolve o uso de técnicas sorológicas para a triagem e de biologia molecular para confirmação do diagnóstico, além de avaliar a eficácia do tratamento. O único tratamento disponível até 2011 era a combinação de Interferon alfa peguilado e Ribavirina. A disponibilidade e a evolução das drogas antivirais de ação direta a partir de 2011 contribuíram com o avanço no tratamento, apresentando alta eficácia, período mais curto de terapia, menos contraindicações e poucos efeitos adversos. Mesmo com esses avanços, apenas 20% das pessoas que vivem com Hepatite C no mundo foram diagnosticadas e 7% receberam tratamento. Conclui-se por tanto que para atingir a meta da OMS será necessário um diagnóstico acessível e rápido, no local de atendimento, além de campanhas de triagem e tratamento em massa como parte do programa de vigilância nacional desse agravo.

31 October 2024 in Acta Tropica
Verified
Journal Article
Closed access
LALais Sampaio de Azevedo
Lais Sampaio de Azevedo
VSVanessa Cristina Martins Silva
Vanessa Cristina Martins Silva
RGRaquel Guiducci
Raquel Guiducci
SGSimone Guadagnucci
Simone Guadagnucci
FCFernanda Faria Costa
Fernanda Faria Costa
Adriana LuchsAdriana Luchs
Adriana Luchs